Ships from British Columbia, Canada|Canadian Orders Ship Domestically, No Border Crossing|International Shipping Available|Lab Verified|>99% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|Ships from British Columbia, Canada|Canadian Orders Ship Domestically, No Border Crossing|International Shipping Available|Lab Verified|>99% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|Ships from British Columbia, Canada|Canadian Orders Ship Domestically, No Border Crossing|International Shipping Available|Lab Verified|>99% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|Ships from British Columbia, Canada|Canadian Orders Ship Domestically, No Border Crossing|International Shipping Available|Lab Verified|>99% Purity Guarantee|Shipped Within 24hr|Batch-Specific COAs|
HomeBlogRegulatory
Regulatory

Semax: Guide to the ACTH-Derived Nootropic Peptide

Semax is a synthetic heptapeptide from the ACTH(4-7) sequence, developed in Russia during the 1980s for neuroprotective and cognitive effects. Research shows it upregulates BDNF and TrkB, improves outcomes in ischemia models, and enhances learning in rodents. This guide covers its structure, mechanisms, and research applications while noting variants like N-Acetyl Semax.

VP

Volta Peptides

Editorial Team

May 12, 2026Updated June 19, 20264 min read
Semax: Guide to the ACTH-Derived Nootropic Peptide

Key Takeaways

  • Semax stands out as a synthetic heptapeptide based on the adrenocorticotropic hormone (ACTH) sequence.
  • Full ACTH, a 39-amino acid peptide, shows effects on learning, memory, and attention separate from adrenal functions.
  • Semax adds a Pro-Gly-Pro extension to the ACTH(4-7) core.

Semax Origins in Russian Peptide Research

Semax stands out as a synthetic heptapeptide based on the adrenocorticotropic hormone (ACTH) sequence. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences created it during the Soviet era, with work starting in the 1980s. It came from a program that yielded several peptides with noted neurological impacts in preclinical studies.

Full ACTH, a 39-amino acid peptide, shows effects on learning, memory, and attention separate from adrenal functions. These tie to the ACTH(4-7) fragment: Met-Glu-His-Phe, the shortest part needed for such activity without steroid effects.

Structure Enhancements for Stability

Semax adds a Pro-Gly-Pro extension to the ACTH(4-7) core. This change boosts metabolic stability, a common issue for short neuropeptides. Proline at key spots blocks enzyme breakdown, and the C-terminal prolyl amide resists carboxypeptidases.

Without this, ACTH(4-7) breaks down quickly via endopeptidases. Semax matches the core's neurological profile but lasts longer in fluids. Russia registered it as nasal drops, a rare approval for a synthetic peptide from that research system.

Interactions with Receptors and BDNF Pathways

The Met-Glu-His-Phe part binds melanocortin receptors, especially MC4R in the central nervous system. It adjusts dopaminergic and serotonergic transmission through unclear steps.

Studies link ACTH(4-7) analogs to higher brain-derived neurotrophic factor (BDNF) in neural tissue. This offers a basis for cognitive and protective effects. Semax reliably raises BDNF and TrkB receptor levels.

BDNF supports neuron survival, maintenance, and growth. It plays a role in synaptic plasticity for learning and memory. Rodent studies show more BDNF mRNA in hippocampus, cortex, and frontal lobe after dosing, with dose-related and lasting effects.

Neuroprotection in Ischemia Models

Semax features in rodent tests of cerebral ischemia, using permanent or transient middle cerebral artery occlusion (MCAO). Such work positions it for probing ischemia protection mechanisms.

In vitro setups like oxygen-glucose deprivation (OGD) in neuron cultures use Semax to check activated pathways. Use our Reconstitution Calculator for preparing solutions in these experiments.

Cognitive and Behavioral Effects

Rodent tests with Morris water maze, novel object recognition, and contextual fear conditioning reveal Semax benefits. It aids spatial learning, memory consolidation, and attention across strains and setups.

These hold in healthy animals, not just impaired ones like age decline, post-ischemia, or cholinergic lesions. This draws interest for baseline cognitive studies. Explore our Peptide Glossary for terms like synaptic plasticity.

Monoamine Neurotransmitter Changes

Semax alters monoamine levels in rodents. Neurochemical analyses note shifts in these dynamics post-administration.

Dopaminergic effects suit study in PC12 cells or ventral mesencephalic cultures. This helps identify molecular targets. Check interactions with our Peptide Interaction Checker.

Variants and Comparisons to Other Peptides

N-Acetyl Semax adds an N-terminal acetyl group for extra stability against aminopeptidases. It lasts longer and may vary in potency, but keeps core actions.

Selank (TKPRPGP), from tuftsin, targets anxiety via GABA and enkephalins. Pairing it with Semax separates cognitive from calming effects.

Peptides like Semax contrast small-molecule nootropics such as amphetamines, racetams, or modafinil. Their size leads to unique pharmacokinetics, often nasal or injected routes, and distinct pharmacology for sustained enhancement research.

Research Administration and Storage

Preclinical work tests Semax via various routes. In vitro, add it to culture media at set levels.

Semax 10mg comes as lyophilized powder for reconstitution. Store dry form at −20°C up to 24 months; keep solutions at 2, 8°C for 28 days. Shield from light to avoid methionine oxidation at position 1. Plan dosages with our Dosage & Cycle Planner and check half-life via Half-Life Calculator.

Semax provides a stable tool for BDNF studies, neuroprotection, and cognition. Its profile supports precise preclinical investigations into brain function.

Research Use Only. This article is provided for informational and educational purposes only. The compounds and topics discussed are intended solely for laboratory and scientific research. This content does not constitute medical advice, and Volta Peptides does not endorse or promote human consumption of any research compound.

More from the Blog

Science

CJC-1295 and Ipamorelin: Human Evidence and Limits

This reference separates what human trials, animal models, and analytical chemistry show about CJC-1295 and ipamorelin from vendor marketing, assessing the strength of the human evidence base and combination-specific safety data.

Aug 17
Science

Retatrutide in Canada: Access, Trials, and Approval Timing

Retatrutide is not yet approved in Canada; access is limited to clinical trials. This article outlines the current status, evidence, and realistic timelines for availability.

Aug 16
Science

CJC-1295 and Ipamorelin Dosage: Evidence and Risks

This reference reviews the evidence on CJC-1295 and ipamorelin dosing, distinguishing what controlled studies support from what remains speculative or vendor-derived.

Aug 16
Science

BPC-157 10mg Research: Preclinical Evidence, Molecular Profile & Quality Standards

BPC-157 10mg research overview covering preclinical evidence, molecular profile, storage, and quality documentation for laboratory use.

Jul 9
Regulatory

BPC-157 Shelf Life: Lyophilized vs Reconstituted Stability Guide

BPC-157 has a finite shelf life that varies by form and storage. Lyophilized powder lasts 12-18 months refrigerated or 24+ months frozen, while reconstituted solution holds for about 28 days under refrigeration. Factors like temperature, light, and handling influence stability, and researchers should watch for signs of degradation to ensure reliable results.

May 12
Science

SS-31 (Elamipretide): A Research Review on ALS, Diaphragm Strength, and Mitochondrial Function

SS-31 (Elamipretide) research for ALS, diaphragm strength, and mitochondrial function. Preclinical evidence review.

Jul 8

Your Cart

Your cart is empty

Browse our catalog to add research compounds.